Persistence with teriparatide in patients with osteoporosis: the UK experience

被引：0
|
作者：
N. K. Arden
S. Earl
D. J. Fisher
C. Cooper
S. Carruthers
M. Goater
机构：
[1] Southampton General Hospital,MRC Epidemiology Resource Centre, University of Southampton
[2] Southampton General Hospital,Department of Rheumatology
[3] Healthcare at Home,undefined
[4] Eli Lilly and Company,undefined
来源：
Osteoporosis International | 2006年 / 17卷
关键词：
Adverse events; Compliance; Osteoporosis; Persistence; Teriparatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1626 / 1629
页数：3
相关论文
共 50 条
  • [31] Occurrence of hypercalciuria in patients with osteoporosis treated with teriparatide
    Miller, Paul D.
    Bilezikian, John P.
    Diaz-Curiel, Manuel
    Chen, Peiqi
    Marin, Fernando
    Krege, John H.
    Wong, Mayme
    Marcus, Robert
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (09): : 3535 - 3541
  • [32] Treatment of osteoporosis with Teriparatide in anorexia nervosa patients
    Sasaki, T.
    Kodama, T.
    Nakamoto, C.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2013, 82 : 98 - 98
  • [33] Characteristics of patients initiating teriparatide for the treatment of osteoporosis
    Foster, S. A.
    Foley, K. A.
    Meadows, E. S.
    Johnston, J. A.
    Wang, S.
    Pohl, G. M.
    Long, S. R.
    OSTEOPOROSIS INTERNATIONAL, 2008, 19 (03) : 373 - 377
  • [34] Teriparatide in patients with osteoporosis and type 2 diabetes
    Schwartz, Ann V.
    Pavo, Imre
    Alam, Jahangir
    Disch, Damon P.
    Schuster, Dara
    Harris, Jennifer M.
    Krege, John H.
    BONE, 2016, 91 : 152 - 158
  • [35] Characteristics of patients initiating teriparatide for the treatment of osteoporosis
    S. A. Foster
    K. A. Foley
    E. S. Meadows
    J. A. Johnston
    S. Wang
    G. M. Pohl
    S. R. Long
    Osteoporosis International, 2008, 19 : 373 - 377
  • [36] Teriparatide Therapy in a Community Setting: Persistence and Use of Other Osteoporosis Medications in DANCE
    Taylor, K.
    Gold, D. T.
    Miller, P.
    Chen, P.
    Wong, M.
    Krohn, K.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S207 - S207
  • [37] EXPERIENCE ON THE USE OF TERIPARATIDE FOR TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    Saparbayeva, M.
    Issayeva, B.
    Issayeva, S.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S377 - S378
  • [38] EXPERIENCE WITH TERIPARATIDE AS TREATMENT OF OSTEOPOROSIS IN THE MOSCOW REGION OF THE RUSSIAN FEDERATION
    Krasulina, K. A.
    Kryukova, I. V.
    Dreval, A. V.
    Polyakova, E. Y.
    Barsukov, I. A.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S293 - S294
  • [39] IS PERSISTENCE WITH THERAPY A PROBLEM IN ITALIAN PATIENTS TREATED WITH TERIPARATIDE FOR SEVERE OSTEOPOROSIS? PRELIMINARY DATA FROM NORTHERN ITALY
    Gandolini, G.
    Massarotti, M.
    Bevilacqua, M.
    Longhi, M.
    Pietrogrande, L.
    Santi, I.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 108 - 108
  • [40] Evaluation of adherence and persistence to teriparatide treatment in patients affected by severe osteoporosis: A multicenter observational real life study
    Migliaccio, S.
    Resmini, G.
    Buffa, A.
    Fornari, R.
    Di Pietro, G.
    Cerocchi, I.
    Dormi, A.
    Gimigliano, F.
    Mule, R.
    Celi, M.
    Frigato, M.
    Lenzi, A.
    Tarantino, U.
    Iolascon, G.
    Malavolta, N.
    BONE, 2011, 48 : S230 - S231
12345